Dr. Ko, EunYoung


Consultant, MD, MS, Breast Surgery,
Oncology Center

Dr EunYoung Ko 300x333
Education

Education

MD, Seoul National University College of Medicine
MS, Seoul National University College of Medicine
Specialty Training

Specialty Training

Fellowship
Department of Surgery, Seoul National University Hospital, Seoul, Korea
Residency
Department of Surgery, Seoul National University Hospital, Seoul, Korea
Internship
Department of Surgery, Seoul National University Hospital, Seoul, Korea
Working Experience

Working Experience

Clinical Professor, Department of Surgery, SMG-SNU Boramae Medical Center, Seoul, Korea
Consultant, MD, Department of Surgery, Dongnam Institute of Radiological & Medical Science, Busan, Korea
Chief of Breast Care Center, SMG-SNU Boramae Medical Center, Seoul, Korea
Chief of Breast Cancer Center, Dongnam Institute of Radiological & Medical Science, Busan, Korea
Consultant, Department of Surgical oncology, Sheikh Khalifa Specialty Hospital, RAK, UAE
Certificate

Certificate

Certificate of physician, Republic of Korea
Certificate of specialist of General Surgery, Republic of Korea
Certificate of specialist of Breast oncologist, Republic of Korea
Certificate of Consultant of General Surgery, United Arab Emirates
Specialty Interests

Specialty Interests

Breast cancer
Breast surgery
Oncoplastic surgery
Prophylactic mastectomy
Nipple sparing mastectomy
Sentinel node biopsy and axillary node dissection
Breast conserving surgery
Reduction mammoplasty
Publication

Publication

• Kang YJ, Ahn SK, Kim SJ, Oh H, Han J, Ko E. Relationship between Mammographic Density and Age in the United Arab Emirates Population. J Oncol. 2019 Aug 5:2019:7351350. PMID: 31467543 PMCID: PMC6701291 DOI: 10.1155/2019/7351350
• Kim H, Jung IM, Yun KW, Heo SC, Ahn YJ, Hwang KT, Lee HW, Koo do H, Ko E, Ahn HS, Shin R, Chung JK. Early outcome of the Korean Diagnosis-Related Groups payment system for appendectomy. Ann Surg Treat Res. 2015 Mar;88(3):126-32. doi: 10.4174/astr.2015.88.3.126. PubMed PMID: 25741491; PubMed Central PMCID:PMC4347045.
• Ahn SK, Moon HG, Ko E, Kim HS, Shin HC, Kim J, You JM, Han W, Noh DY. Preoperative serum tissue polypeptide-specific antigen is a valuable prognostic marker in breast cancer. Int J Cancer. 2013 Feb 15;132(4):875-81. doi: 10.1002/ijc.27727. PubMed PMID: 22815188.
• Lee JM, Lee JS, Kim H, Kim K, Park H, Kim JY, Lee SH, Kim IS, Kim J, Lee M, Chung CH, Seo SB, Yoon JB, Ko E, Noh DY, Kim KI, Kim KK, Baek SH. EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex. Mol Cell. 2012 Nov 30;48(4):572-86. doi: 10.1016/j.molcel.2012.09.004. PubMed PMID: 23063525.
• Hong SW, Lee SH, Moon JH, Hwang JJ, Kim DE, Ko E, Kim HS, Cho IJ, Kang JS, Kim DJ, Kim JE, Shin JS, Jung DJ, Jeong YJ, Cho BJ, Kim TW, Lee JS, Kang JS, Hwang YI, Noh DY, Jin DH, Lee WJ. SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment. Oncogene. 2013 Mar 21;32(12):1508-17. doi: 10.1038/onc.2012.176. PubMed PMID: 22665050.
• Lee KM, Han W, Kim JB, Shin I, Ko E, Park IA, Lee DS, Oh K, Noh DY. The CD49d+/high subpopulation from isolated human breast sarcoma spheres possesses tumor-initiating ability. Int J Oncol. 2012 Mar;40(3):665-72. doi:10.3892/ijo.2011.1289. PubMed PMID: 22159714.
• Han W, Woo JH, Jeon YK, Yang SJ, Cho J, Ko E, Kim TY, Im SA, Oh DY, Park IA, Hwang KT, Moon HG, Yang KS, Noh DY. 17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy. Exp Ther Med. 2011 Sep;2(5):799-804. PubMed PMID: 22977578; PubMed Central PMCID: PMC3440692.
• Oh K, Ko E, Kim HS, Park AK, Moon HG, Noh DY, Lee DS. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells. Breast Cancer Res. 2011 Oct 3;13(5):R96. doi:10.1186/bcr3034. PubMed PMID: 21967801; PubMed Central PMCID: PMC3262209.
• Moon HG, Hwang KT, Kim JA, Kim HS, Lee MJ, Jung EM, Ko E, Han W, Noh DY. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol.2011 Dec;5(6):538-44. doi: 10.1016/j.molonc.2011.08.002. PubMed PMID: 21925980.
• Kim EK, Kim HA, Koh JS, Kim MS, Kim KI, Lee JI, Moon NM, Ko E, Noh WC.Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2011 Feb;126(1):93-9. doi: 10.1007/s10549-010-1315-z. PubMed PMID: 21184268.
• Choi HJ, Lee JM, Kim H, Nam HJ, Shin HJ, Kim D, Ko E, Noh DY, Kim KI, Kim JH, Baek SH. Bcl3-dependent stabilization of CtBP1 is crucial for the inhibition of apoptosis and tumor progression in breast cancer. Biochem Biophys Res Commun. 2010 Sep 24;400(3):396-402. doi: 10.1016/j.bbrc.2010.08.084. PubMed PMID: 20800578.
• Kim ES, Jeong JB, Kim S, Lee KM, Ko E, Noh DY, Hwang KT, Ha JH, Lee CH, Kim SG, Moon A. The G12 family proteins upregulate matrix metalloproteinase-2 via p53 leading to human breast cell invasion. Breast Cancer Res Treat. 2010 Nov;124(1):49-61. doi: 10.1007/s10549-009-0697-2. PubMed PMID: 20044778.
• Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY, Shin I, Han W, Noh DY. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine. 2010 May;17(6):436-40. doi: 10.1016/j.phymed.2009.08.012. PubMed PMID: 19800775.
• Yi JK, Chang JW, Han W, Lee JW, Ko E, Kim DH, Bae JY, Yu J, Lee C, Yu MH, Noh DY. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1357-64. doi: 10.1158/1055-9965.EPI-08-0696. PubMed PMID: 19423516.
• Ko E, Han W, Cho J, Lee JW, Kang SY, Jung SY, Kim EK, Hwang KT, Noh DY. Fibrin glue reduces the duration of lymphatic drainage after lumpectomy and level II or III axillary lymph node dissection for breast cancer: a prospective randomized trial. J Korean Med Sci. 2009 Feb;24(1):92-6. doi:10.3346/jkms.2009.24.1.92. PubMed PMID: 19270819; PubMed Central PMCID: PMC2650992.
• Jung SY, Han W, Lee JW, Ko E, Kim E, Yu JH, Moon HG, Park IA, Oh DY, Im SA, Kim TY, Hwang KT, Kim SW, Noh DY. Ki-67 expression gives additional prognostic information on St. Gallen 2007 and Adjuvant! Online risk categories in early breast cancer. Ann Surg Oncol. 2009 May;16(5):1112-21. doi: 10.1245/s10434-009-0334-7. PubMed PMID: 19219507.
• Kim JB, Ko E, Han W, Shin I, Park SY, Noh DY. Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells. Planta Med. 2008 Nov;74(14):1693-700. doi: 10.1055/s-0028-1088313. PubMed PMID: 18951337.
• Hwang KT, Han W, Cho J, Lee JW, Ko E, Kim EK, Jung SY, Jeong EM, Bae JY, Kang JJ, Yang SJ, Kim SW, Noh DY. Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer. Int J Cancer. 2008 Oct 15;123(8):1807-15. doi: 10.1002/ijc.23672. PubMed PMID: 18649361.
• Cho J, Han W, Lee JW, Ko E, Kang SY, Jung SY, Kim EK, Moon WK, Cho N, Park IA, Chung JK, Hwang KT, Kim SW, Noh DY. A scoring system to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a comparison with other scoring systems. Ann Surg Oncol. 2008 Aug;15(8):2278-86. doi: 10.1245/s10434-008-9993-z. PubMed PMID: 18528729.
• Lee JW, Han W, Ko E, Cho J, Kim EK, Jung SY, Cho N, Moon WK, Park IA, Noh DY. Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus. J Surg Oncol. 2008 Jul 1;98(1):15-20. doi:10.1002/jso.21077. PubMed PMID: 18459155.
• Ko E, Kim JB, Han W, Lee JE, Lee KM, Shin I, Kim S, Lee JW, Cho J, Bae JY, Jee HG, Noh DY. CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells. BMC Cancer. 2008 Apr 24;8:118. doi: 10.1186/1471-2407-8-118. PubMed PMID: 18433506; PubMed Central PMCID: PMC2386794.
• Kim JB, Lee KM, Ko E, Han W, Lee JE, Shin I, Bae JY, Kim S, Noh DY. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med. 2008 Jan;74(1):39-42. doi: 10.1055/s-2007-993779. PubMed PMID: 18203057.
• Ko E, Han W, Lee JW, Cho J, Kim EK, Jung SY, Kang MJ, Moon WK, Park IA, Kim SW, Kim KS, Lee ES, Min KH, Kim SW, Noh DY. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy. Breast Cancer Res Treat. 2008 Nov;112(1):189-95. PubMed PMID: 18060577.
• Kim HJ, Kim JB, Lee KM, Shin I, Han W, Ko E, Bae JY, Noh DY. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7. Cancer Lett. 2007 Dec 8;258(1):98-108. PubMed PMID: 17950993.